Product Details

Act Ciprofloxacin

Ciprofloxacin
250 mg
Tablet


DIN/PIN/NPN

02247339

Manufacturer

Teva Canada Limited

Formulary Listing Date

2004-07-20  

Unit Price

0.4454

Amount MOH Pays

0.4454

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Ciprofloxacin: Ciprofloxacin is not intended for the treatment of asymptomatic bacteriuria in the absence of risk factors. Avoid use in pregnancy and children <18>

ATC Code

J01MA02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02161737 Teva-Ciprofloxacin 0.4454 0.4454
02379627 Septa-Ciprofloxacin 0.4454 0.4454
02248756 Sandoz Ciprofloxacin 0.4454 0.4454
02246825 Ratio-Ciprofloxacin 0.4454 0.4454
02303728 Ran-Ciproflox 0.4454 0.4454
02248437 PMS-Ciprofloxacin 0.4454 0.4454
02423553 Mint-Ciproflox 0.4454 0.4454
02379686 Mar-Ciprofloxacin 0.4454 0.4454
02380358 Jamp-Ciprofloxacin 0.4454 0.4454
02247339 Act Ciprofloxacin 0.4454 0.4454
02386119 Ciprofloxacin 0.4454 0.4454
02353318 Ciprofloxacin 0.4454 0.4454
02155958 Cipro NA NA
02381907 Auro-Ciprofloxacin 0.4454 0.4454
02229521 Apo-Ciproflox 0.4454 0.4454
 

LU Clinical Criteria

NO  

Requirements


EAP Criteria

  NO

Product Monograph

View Monograph